Related articles:
Etoricoxib
Naproxen
Celecoxib
Aspirin
Cyclooxygenase
Diclofenac
Ibuprofen
Osteoarthritis
Clinical trial
Acne vulgaris
Key terms:
merck
vioxx
rofecoxib
fda
vigor
cardiovascular
et al
heart attack
nejm
nsaids
inhibitors
naproxen
pmid
aspirin
topol
plaintiff
celecoxib
relative risk
jama
lancet
cardiovascular events
reuben
punitive
prostacyclin
approve study
increased risk
arrhythmia
grassley
vioxx usage
prostaglandins
clinical trial
n engl j med
myocardial infarction
cardiovascular risk
acute pain
vigor study
cutoff date
merck argued
nonsteroidal
vioxx litigation
risk of heart attack
new england journal
adverse cardiovascular events
statistically significant
cardiovascular safety
adverse effect profile
effect of naproxen
increased relative risk
three additional heart attacks
risk of adverse cardiovascular events
Search external links cited by footnotes on Wikipedia page Rofecoxib:
|
|